2003 Fiscal Year Final Research Report Summary
The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric epithelial cells ; ADAM10 mediates IL-8-induced EGFR transactivation
| Project/Area Number |
14570489
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Nagoya City University |
|---|
Principal Investigator |
SASAKI Makoto Nagoya City University, Graduate School of Medical Sciences, Research Associate, 大学院・医学研究科, 助手 (70360873)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HIGASHIYAMA Shigeki Ehime University, School of Medicine, Professor and Chair, 医学部, 教授 (60202272)
TAKASHI Joh Nagoya City University, Graduate School of Medical Sciences, Associate Professor, 大学院・医学研究科, 助教授 (30231369)
|
|---|
| Project Period (FY) |
2002 – 2003
|
| Keywords | GPCR / ADAM / inflammatory cytokines / shedding / EGFR ligands / siRNA |
|---|
| Research Abstract |
The epidermal growth factor receptor (EGFR) can be transactivated by many factors including G-protein-coupled receptor (GPCR) agonists and cytokines. EGFR transactivation requires a disintegrin and metalloproteinase (ADAM), which sheds EGFR ligands. In order to investigate the mechanism of EGFR transactivation induced by IL-8 (GPCR agonist) and IL-1β(non-GPCR agonist) which play critical roles in Helicobacter pylori-associated gastritis, we assessed IL-8-and IL-1β-dependent ectodomain shedding of EGFR-ligand using KATO III cell transfectants stably expressing alkaline phosphatase (AP)-tagged heparin-binding EGF-like growth factor (HB-EGF), TGF-α, or amphiregulin (AR) precursors as well as siRNA against ADAM10, 12, or 17. IL-8 dose-dependently released the EGFR ligands (HB-EGF>AR>TGF-α), and transiently phosphorylated EGFR with a peak at 15 min after stimulation. A metalloproteinase inhibitor, KB-R7785, completely blocked shedding of the ligands and EGFR transactivation. Depletion of ADAM10 by siRNA significantly reduced the EGFR transactivation, but those of ADAM12 and 17 did not. IL-1β dose-dependently enhanced shedding of HB-EGF, which was not inhibited by KB-R7785 in the early phase. The EGFR transactivation in the late phase was, however, blocked by KB-R7785 and abrogated by anti-IL-8 neutralizing antibody. These results indicate that IL-8 induces shedding of EGFR ligands due to an ADAM 10-dependent pathway in gastric epithelial cells, while IL-1β acts principally by an ADAM-independent pathway. Both cytokines transactivate EGFR, and IL-1β-dependent prolonged EGFR transactivation involves multiple pathways, including an IL-8-dependent pathway.
|
-
-
-
-
-
-
-
[Publications] Satoshi Tanida, Takashi Joh, Keisuke Itoh, Hiromi Kataoka, Makoto Sasaki, Hirotaka Ohara, Takahiro Nakazawa, Tomoyuki Nomura, Yumi Kinugasa, Hiroshi Ohmoto, Hiroshi Ishiguro, Kohichiro Yoshino, Shigeki Higashiyama, Makoto Itoh: "The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells"Gastroenterology. (in press).
Description
「研究成果報告書概要(欧文)」より
